Identification of extended-spectrum, AmpC, and carbapenem-hydrolyzing β-lactamases in Escherichia coli and Klebsiella pneumoniae by disk tests

Journal of Clinical Microbiology

Volumn 44, Issue 6, 2006, Pages 1971-1976

  Jacoby, George A ^a   Walsh, Kelley E ^a   Walker, Victoria J ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOBENZENEBORONIC ACID; ANTIBIOTIC DISK; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE AMPC; BORONIC ACID DERIVATIVE; CARBAPENEM; CARBAPENEM HYDROLYZING BETA LACTAMASE; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CLAVULANIC ACID; EDETIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; OUTER MEMBRANE PROTEIN; PORIN; UNCLASSIFIED DRUG;

ANALYTICAL EQUIPMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; DISK TEST; ENZYME ANALYSIS; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; LABORATORY TEST; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CEFOXITIN; CLAVULANIC ACID; EDETIC ACID; ESCHERICHIA COLI; HUMANS; HYDROLYSIS; IMIPENEM; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS;

ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

EID: 33745125734     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00062-06     Document Type: Article

References (46)

1. Alvarez, M., J. H. Tran, N. Chow, and G. A. Jacoby. 2004. Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States. Antimicrob. Agents Chemother. 48:533-537.
2. Arakawa, Y., N. Shibata, K. Shibayama, H. Kurokawa, T. Yagi, H. Kujiwara, and M. Goto. 2000. Convenient test for screening metallo-β-lactamase- producing gram-negative bacteria by using thiol compounds. J. Clin. Microbiol. 38:40-43.
3. Arlet, G., M. Rouveau, D. Bengoufa, M. H. Nicolas, and A. Philippon. 1991. Novel transferable extended-spectrum β-lactamase (SHV-6) from Klebsiella pneumoniae conferring selective resistance to ceftazidime. FEMS Microbiol. Lett. 81:57-62.
4. Bauernfeind, A., I. Schneider, R. Jungwirth, H. Sahly, and U. Ullmann. 1999. A novel type of AmpC β-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia. Antimicrob. Agents Chemother. 43:1924-1931.
5. Ben Redjeb, S., G. Fournier, C. Mabilat, A. Ben Hassen, and A. Philippon. 1990. Two novel transferable extended-spectrum β-lactamases from Klebsiella pneumoniae in Tunisia. FEMS Microbiol. Lett. 67:33-38.
6. Black, J. A., K. S. Thomson, J. D. Buynak, and J. D. Pitout. 2005. Evaluation of β-lactamase inhibitors in disk tests for detection of plasmid-mediated AmpC β-lactamases in well-characterized clinical strains of Klebsiella spp. J. Clin. Microbiol. 43:4168-4171.
7. Bou, G., A. Oliver, M. Ojeda, C. Monzón, and J. Martínez-Beltran. 2000. Molecular characterization of FOX-4, a new AmpC-type plasmid-mediated β-lactamase from an Escherichia coli strain isolated in Spain. Antimicrob. Agents Chemother. 44:2549-2553.
8. Bradford, P. A., Y. Yang, D. Sahm, I. Grope, D. Gardovska, and G. Storch. 1998. CTX-M-5, a novel cefotaxime-hydrolyzing β-lactamase from an outbreak of Salmonella typhimurium in Latvia. Antimicrob. Agents Chemother. 42:1980-1984.
9. Buré, A., P. Legrand, G. Arlet, V. Jarlier, G. Paul, and A. Philippon. 1988. Dissemination in five French hospitals of Klebsiella pneumonias serotype K25 harboring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam. Eur. J. Clin. Microbiol. 7:780-782.
10. Chanal, C. M., D. L. Sirot, A. Petit, R. Labia, A. Morand, J. L. Sirot, and R. A. Cluzel. 1989. Multiplicity of TEM-derived β-lactamases from Klebsiella pneumoniae strains isolated at the same hospital and relationships between the responsible plasmids. Antimicrob. Agents Chemother. 33:1915-1920.
11. CLSI. 2003. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. Clinical and Laboratory Standards Institute, Wayne, Pa.
12. Gonzalez Leiza, M., J. C. Perez-Diaz, J. Ayala, J. M. Casellas, J. Martinez-Beltran, K. Bush, and F. Baquero. 1994. Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated β-lactamase with two molecular variants. Antimicrob. Agents Chemother. 38:2150-2157.
13. Gutmann, L., M. D. Kitzis, D. Billot-Klein, F. Goldstein, G. Tran Van Nhieu, T. Lu, J. Carlet, E. Collatz, and R. Williamson. 1988. Plasmid-mediated β-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam. Rev. Infect. Dis. 10:860-866.
14. Hernández-Allés, S., M. Conejo, A. Pascual, J. M. Tomás, V. J. Benedí, and L. Martínez-Martínez. 2000. Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae. J. Antimicrob. Chemother. 46:273-277.
15. Horii, T., Y. Arakawa, M. Ohta, S. Ichiyama, R. Wacharotayankun, and N. Kato. 1993. Plasmid-mediated AmpC-type β-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum β-lactams, including moxalactam. Antimicrob. Agents Chemother. 37:984-990.
16. Jacoby, G. A., and P. Han. 1996. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J. Clin. Microbiol. 34:908-911.
17. Jacoby, G. A., A. A. Medeiros, T. F. O'Brien, M. E. Pinto, and H. Jiang. 1988. Broad-spectrum, transmissible β-lactamases. N. Engl. J. Med. 319:723-724.
18. Jacoby, G. A., and L. S. Munoz-Price. 2005. The new β-lactamases. N. Engl. J. Med. 352:380-391.
19. Jacoby, G. A., and R. Vacheva-Dobrevsky. 2003. Epidemiology of extended-spectrum β-lactmases in Sofia, Bulgaria. Eur. J. Clin. Microbiol. Infect. Dis. 22:385-388.
20. Jacoby, G. A., K. E. Walsh, D. M. Mills, V. J. Walker, H. Oh, A. Robicsek, and D. C. Hooper. 2006. qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob. Agents Chemother. 50:1178-1182.
21. Lee, K., Y. S. Lim, D. Yong, J. H. Yum, and Y. Chong. 2003. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 41:4623-4629.
22. Livermore, D. M. 1995. β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
23. Marchese, A., G. Arlet, G. C. Schito, P. H. Lagrange, and A. Philippon. 1998. Characterization of FOX-3, an AmpC-type plasmid-mediated β-lactamase from an Italian isolate of Klebsiella oxytoca. Antimicrob. Agents Chemother. 42:464-467.
24. Martínez-Martínez, L., A. Pascual, S. Hernández- Allés, D. Alvarez-Díaz, A. I. Suarez, J. Tran, V. J. Benedí, and G. A. Jacoby. 1999. Roles of β-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob. Agents Chemother. 43:1669-1673.
25. Mulvey, M. R., E. Bryce, D. A. Boyd, M. Ofner-Agostini, A. M. Land, A. E. Simor, and S. Paton. 2005. Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob. Agents Chemother. 49:358-365.
26. Nadjar, D., M. Rouveau, C. Verdet, J. Donay, J. Herrmann, P. H. Lagrange, A. Philippon, and G. Arlet. 2000. Outbreak of Klebsiella pneumoniae producing transferable AmpC-type β-lactamase (ACC-1) originating from Hafnia alvei. FEMS Microbiol. Lett. 187:35-40.
27. Nicolas, M. H., V. Jarlier, N. Honore, A. Philippon, and S. T. Cole. 1989. Molecular characterization of the gene encoding SHV-3 β-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 33:2096-2100.
28. Pai, H., E. H. Choi, H. J. Lee, J. Y. Hong, and G. A. Jacoby. 2001. Identification of CTX-M-14 extended-spectrum β-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea. J. Clin. Microbiol. 39:3747-3749.
29. Pai, H., H. J. Lee, E. H. Choi, J. Kim, and G. A. Jacoby. 2001. Evolution of TEM-related extended-spectrum β-lactamases in Korea. Antimicrob. Agents Chemother. 45:3651-3653.
30. Papanicolaou, G. A., A. A. Medeiros, and G. A. Jacoby. 1990. Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 34:2200-2209.
31. Paterson, D. L., and R. A. Bonomo. 2005. Extended-spectrum β-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
32. Paul, G. C., G. Gerbaud, A. Bure, A. M. Philippen, B. Pangon, and P. Courvalin. 1989. TEM-4, a new plasmid-mediated β-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli. Antimicrob. Agents Chemother. 33:1958-1963.
33. Petit, A., D. L. Sirot, C. M. Chanal, J. L. Sirot, R. Labia, G. Gerbaud, and R. A. Cluzel. 1988. Novel plasmid-mediated β-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins. Antimicrob. Agents Chemother. 32:626-630.
34. Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J. D. Cavallo, and P. Nordmann. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891-897.
35. Poupart, M. C., C. Chanal, D. Sirot, R. Labia, and J. Sirot. 1991. Identification of CTX-2, a novel cefotaximase from a Salmonella mbandaka isolate. Antimicrob. Agents Chemother. 35:1498-1500.
36. Rasheed, J. K., G. J. Anderson, A. M. Queenan, J. W. Biddle, A. Oliver, G. A. Jacoby, K. Bush, and F. C. Tenover. 2002. TEM-71, a novel plasmid-encoded, extended-spectrum β-lactamase produced by a clinical isolate of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 46:2000-2003.
37. Rasheed, J. K., G. J. Anderson, H. Yigit, A. M. Queenan, A. Doménech-Sánchez, J. M. Swenson, J. W. Biddle, M. J. Ferraro, G. A. Jacoby, and F. C. Tenover. 2000. Characterization of the extended-spectrum β-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18. Antimicrob. Agents Chemother. 44:2382-2388.
38. Raskine, L., I. Borrel, G. Barnaud, S. Boyer, B. Hanau-Bercot, J. Gravisse, R. Labia, G. Arlet, and M. J. Sanson-Le-Pors. 2002. Novel plasmid-encoded class C β-lactamase (MOX-2) in Klebsiella pneumoniae from Greece. Antimicrob. Agents Chemother. 46:2262-2265.
39. Rice, L. B., S. H. Willey, G. A. Papanicolaou, A. A. Medeiros, G. M. Eliopoulos, R. C. Moellering, Jr., and G. A. Jacoby. 1990. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility. Antimicrob. Agents Chemother. 34:2193-2199.
40. Smith Moland, E., N. D. Hanson, V. L. Herrera, J. A. Black, T. J. Lockhart, A. Hossain, J. A. Johnson, R. V. Goering, and K. S. Thomson. 2003. Plasmid-mediated, carbapenem-hydrolysing β-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J. Antimicrob. Chemother. 51:711-714.
41. Spencer, R. C., P. F. Wheat, T. G. Winstanley, D. M. Cox, and S. J. Plested. 1987. Novel β-lactamase in a clinical isolate of Klebsiella pneumoniae conferring unusual resistance to β-lactam antibiotics. J. Antimicrob. Chemother. 20:919-921.
42. Tzouvelekis, L. S., E. Tzelepi, A. F. Mentis, and A. Tsakris. 1993. Identification of a novel plasmid-mediated β-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae. J. Antimicrob. Chemother. 31:645-654.
43. Vuye, A., G. Verschraegen, and G. Claeys. 1989. Plasmid-mediated β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime. Antimicrob. Agents Chemother. 33:757-761.
44. Wang, M., J. H. Tran, G. A. Jacoby, Y. Zhang, F. Wang, and D. C. Hooper. 2003. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob. Agents Chemother. 47:2242-2248.
45. Woodford, N., P. M. Tierno, Jr., K. Young, L. Tysall, M. F. Palepou, E. Ward, R. E. Painter, D. F. Suber, D. Shungu, L. L. Silver, K. Inglima, J. Kornblum, and D. M. Livermore. 2004. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β-lactamase, KPC-3, in a New York medical center. Antimicrob. Agents Chemother. 48:4793-4799.
46. Yagi, T., J. Wachino, H. Kurokawa, S. Suzuki, K. Yamane, Y. Doi, N. Shibata, H. Kato, K. Shibayama, and Y. Arakawa. 2005. Practical methods using boronic acid compounds for identification of class C β-lactamase-producing Klebsiella pneumoniae and Escherichia coli. J. Clin. Microbiol. 43:2551-2558.